Healthcare’s leading the tape this afternoon.

You can feel it in the screen.

What’s less obvious is the only thing that matters: did today’s move create an opportunity… or did it just remove one of the uglier downside scenarios?

Those aren’t the same trade. And they don’t pay you the same way.

What Actually Changed

The catalyst is clean:

• CMS finalized a 2.48% Medicare Advantage (MA) rate increase
• Earlier in the year, this looked close to flat
• Once you layer in the usual adjustments, the all-in impact is closer to ~5%

That’s not a rounding error.

For MA insurers, reimbursement is the oxygen tank. A few percentage points changes how much breathing room they have.

And when margins are thin, “a little better” can show up as “a lot better” in earnings expectations.

Why the Market Reacted So Fast

Managed care doesn’t get to raise prices on a whim.

So when the government nudges the rate environment higher, the market immediately starts doing the math on three things:

• Less margin squeeze
• More flexibility on benefits (which helps retention and competitiveness)
• Cleaner earnings visibility (less “what if CMS cuts us?”)

That’s enough to light a fire under a group that’s spent a while eating bad news.

But let’s not do the lazy thing.

“Better” doesn’t automatically mean “cheap.”

Expectations vs. Reality

MA is basically a two-variable problem:

• What you get paid (CMS rates, risk adjustment, star ratings)
• What care costs (utilization, severity, unit inflation)

Over the last year, the market started to lean toward a nasty combo: reimbursement stays tight and medical costs stay hot.

This CMS update doesn’t cool utilization. It doesn’t magically make providers cheaper. It doesn’t fix execution.

What it does do is take one big source of uncertainty and move it in the right direction.

That’s why you’re seeing a pop.

Now the question becomes: relief rally… or a real re-rating? That comes down to valuation versus sustainable earnings.

How These Businesses Make Money

Here’s the plain-English model:

• Insurer gets paid a fixed amount per member (risk-adjusted, quality-adjusted)
• Insurer pays medical claims + admin costs
• If they manage it well, the spread becomes profit

Two things to keep in mind, bargain hunter:

• Small rate shifts hit hard because costs don’t behave politely.
• Scale is a weapon (admin leverage, contracting power, data).

That’s why this space can look sleepy… right up until it doesn’t. When trend surprises, earnings don’t “adjust.” They gap down. Or up.

The Numbers Worth Anchoring To

Let’s keep it grounded in what’s knowable.

1) The rate math

• Final MA rate increase: 2.48%
• All-in impact with adjustments: ~5%
• What it signals: less revenue pressure than the market feared

2) The stuff that still decides winners

• Medical cost trend: does it cool, or does it stay stubborn?
• Stars dynamics: quality bonuses (or penalties) can swing profitability
• Risk adjustment execution: documentation and coding matter more than people admit

Translation: this is a tailwind. Not a shield.

The Only Two Questions That Matter

Is UnitedHealth cheap?

Is Humana cheap?

UnitedHealth (UNH): Quietly Getting More Ownable

UNH is around ~18x earnings.

Not a fire sale. But not silly, either—especially for a company with:

• scale that’s hard to replicate
• diversified earnings power (insurance + Optum)
• a reimbursement backdrop that just improved

The key: the “expectations reset” already happened here. A lot of the fear was in the price.

So when one variable turns from headwind to tailwind, UNH doesn’t need perfection to work.

That’s what value often looks like in real time: not cheap enough to brag about, but stable enough that fewer things have to go right.

Humana (HUM): The “Cheap” That Can Still Be Expensive

HUM gets the bigger move because it’s more directly tied to MA. That part is rational.

But the stock can look like a bargain while the earnings base is still sliding around.

What’s sitting in the middle of this:

• 2026 EPS guidance around $9
• Old expectations were closer to $12
• Star ratings headwind that management has called out as a multi-year profit drag

And despite that, you’re still looking at roughly ~24x on that guidance.

So yes—today’s news helps HUM.

But what you’re seeing isn’t “cheap getting cheaper.”

It’s pressure getting relieved.

Different animal.

Is It Cheap?: The Valuation Trap

In managed care, quoting a P/E without talking about earnings quality is like pricing a used car without opening the hood.

Because the “E” is volatile when:

• utilization surprises
• stars move against you
• risk adjustment changes

The right framing is: what’s a realistic mid-cycle earnings number once costs normalize and rates are known?

That’s where “cheap” lives. Not in a screenshot of today’s multiple.

What the Market Might Be Over-Discounting

The rally assumes the storm passed.

More accurate: the wind changed direction a bit.

This rate update helps—but it doesn’t make these risks disappear:

• utilization staying elevated
• regulatory grind
• execution risk (HUM wears more of this)

So yes, conditions improved.

But blanket “buy the sector” takes are how people end up paying full price for a partial fix.

Bull / Base / Bear

Bull

Rates improve, utilization cools, and guidance stops wobbling.

→ UNH grinds higher; HUM has more upside torque as sentiment flips

Base

Rates help, but cost pressure and operational issues don’t vanish.

→ UNH behaves; HUM stays a roller coaster

Bear

Medical trend stays ugly and the rate bump isn’t enough.

→ You get a relief rally that fades when estimates roll over again

Action Plan for the Bargain Hunter

This isn’t a “back up the truck” moment.

It’s a “buy the version you can actually hold through a headline cycle” moment.

• UNH: steadier business + improving backdrop
• HUM: more torque, but you’re underwriting a fix—not just a rate tailwind

A simple (conservative) scale-in

• Start small. Let the tape calm down.
• Add on confirmation. Next quarter: trend and guidance need to cooperate.
• Size HUM like a special situation. Not like a bond proxy.

Cheap Investor Checklist (Print This in Your Head)

• Medical cost trend: cooling or stubborn?
• Benefit posture: adding benefits back, or still cutting?
• Stars trajectory: improving, stable, or drifting lower?
• Estimate revisions: are numbers finally moving up?
• Margin language: “contained” vs. “persisting”
• Membership quality: profitable growth or growth at any price?
• Cash conversion: does earnings power show up in cash?
• Valuation on mid-cycle EPS: not just this year’s stressed number

Bottom Line

Today’s move isn’t crazy. The market just priced out a chunk of fear.

But fear coming out of the price is not the same thing as value going in.

If you want the cleanest exposure, UNH looks like the “fewer things have to go right” option.

If you want torque, HUM can give it to you—but only if the earnings base stops sliding.

Because in this kind of tape, bargain hunter…

The best trades aren’t the ones that bounce the hardest.

They’re the ones that quietly end up with fewer things going wrong.